OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of Resistance to Antibody-Drug Conjugates
Rita Khoury, Khalil Saleh, Nadine Khalife, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9674-9674
Open Access | Times Cited: 54
Rita Khoury, Khalil Saleh, Nadine Khalife, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9674-9674
Open Access | Times Cited: 54
Showing 51-75 of 54 citing articles:
Mechanisms of resistance of antibody-drug conjugates—Obstacles to overcome
Yanitsa Davidkova, Milan Jagurinoski, Margarita Guenova
Elsevier eBooks (2024), pp. 257-273
Closed Access
Yanitsa Davidkova, Milan Jagurinoski, Margarita Guenova
Elsevier eBooks (2024), pp. 257-273
Closed Access
The Impact of Genetic Mutations on the Efficacy of Immunotherapies in Lung Cancer
Ki Lui, Kwok‐Kuen Cheung, Winnie Wing Man Ng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11954-11954
Open Access
Ki Lui, Kwok‐Kuen Cheung, Winnie Wing Man Ng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11954-11954
Open Access
Case report: Two cases of leptomeningeal metastases in patients with metastatic urothelial carcinoma treated with enfortumab vedotin
Francine Fishbein, Lucia Nappi, Behnoush Mortazavi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Francine Fishbein, Lucia Nappi, Behnoush Mortazavi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
David J. Benjamin, Alain C. Mita
Targeted Oncology (2024)
Closed Access
David J. Benjamin, Alain C. Mita
Targeted Oncology (2024)
Closed Access
Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine
Saif Khan, Suresh Babu Jandrajupalli, Nashwa Zaki Ali Bushara, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2126-2126
Open Access
Saif Khan, Suresh Babu Jandrajupalli, Nashwa Zaki Ali Bushara, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2126-2126
Open Access
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure
Bożena Sikora-Kupis, Piotr Domański, Weronika Fortuniak, et al.
Współczesna Onkologia (2023) Vol. 27, Iss. 4, pp. 224-229
Open Access
Bożena Sikora-Kupis, Piotr Domański, Weronika Fortuniak, et al.
Współczesna Onkologia (2023) Vol. 27, Iss. 4, pp. 224-229
Open Access
